Published in Obesity and Diabetes Week, May 1st, 2006
According to a study from Japan, "Using Zucker fatty rats, a strain characterized by diabetes and hyperlipidemia, we investigated the diabetes- and hyperlipidemia-related impairment of bone marrow mononuclear cells (BMCs) for inducing therapeutic angiogenesis. BMCs from Zucker fatty and normal Zucker lean rats were collected and cultured."
"Although the characterization and cell survival of BMCs did not differ, the vascular endothelial growth factor (VEGF) production, endothelial differentiation, and endothelial cell colony-forming potential of BMCs from Zucker fatty rats...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week